Search

everythinglearnresearchcommunity

for

Search:↓

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Fat, bone, and the brain are interconnected in regulating energy and health.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Exosome therapy could revolutionize stroke treatment, but more research is needed for human use.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.

Early detection and treatment are crucial to prevent irreversible hair loss in Lichen Planopilaris.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Minoxidil helps hair regrowth by stimulating hair follicles and reducing immune responses.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

A 29-year-old man had a jaw plaque diagnosed as follicular mucinosis, linked to nestin-positive hair follicle stem cells.

A young woman had a rare, usually non-cancerous tumor on her face that was initially mistaken for a different condition.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

The hairless (hr) gene is essential for normal hair follicle function and its mutation leads to hair loss.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.